Challenges in the diagnosis of the enigmatic primary adrenal leiomyosarcoma: two case reports and review of the literature
Sawako Suzuki,Naoya Takahashi,Masafumi Sugo,Kazuki Ishiwata,Akiko Ishida,Suzuka Watanabe,Katsushi Igarashi,Yutaro Ruike,Kumiko Naito,Masanori Fujimoto,Hisashi Koide,Yusuke Imamura,Shinichi Sakamoto,Tomohiko Ichikawa,Yoshihiro Kubota,Takeshi Wada,Yuto Yamazaki,Hironobu Sasano,Jun-Ichiro Ikeda,Ichiro Tatsuno,Koutaro Yokote
DOI: https://doi.org/10.1186/s12902-023-01530-z
2023-12-18
Abstract:Background: Primary adrenal leiomyosarcoma is a rare and aggressive mesenchymal tumor derived from the smooth muscle wall of a central adrenal vein or its tributaries; therefore, tumors tend to invade the inferior vena cava and cause thrombosis. The great majority of tumors grow rapidly, which makes the disease difficult to diagnose in its early clinical stages and needs differentiation from adrenocortical carcinomas for the selection of chemotherapy including mitotane which causes adrenal insufficiency. Case presentation: We presented two patients with adrenal leiomyosarcoma who were referred to our hospital with abdominal pain and harboring large adrenal tumors and inferior vena cava thrombosis. The endocrine findings, including serum catecholamine levels, were unremarkable. These two patients were considered clinically inoperable, and CT-guided core needle biopsy was performed to obtain the definitive histopathological diagnosis and determine the modes of therapy. The masses were subsequently diagnosed as primary adrenal leiomyosarcoma based on the histological features and positive immunoreactivity for SMA (smooth muscle actin), desmin, and vimentin. Conclusions: Adrenal leiomyosarcoma derived from the smooth muscle wall of a central adrenal vein or its tributaries is rare but should be considered a differential diagnosis in the case of nonfunctioning adrenal tumors extending directly to the inferior vena cava. CT-guided biopsy is considered useful for histopathological diagnosis and clinical management of patients with inoperable advanced adrenal tumors without any hormone excess.